Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic Dermatitis
Clinical trial NCT07734415 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07734415
- Sponsor
- Inmagene LLC
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-06-05
- Primary completion
- 2028-03-01
- Enrollment
- 400
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.